Startups
ChronicleBio
US biotechnology company developing an AI and multi-omics platform to discover treatments for complex chronic and neuroimmune conditions. It combines longitudinal clinical information and biological samples from its Chronicle Biobank with large biological models to identify disease mechanisms, distinguish patient subgroups and guide therapeutic development. Its work aims to translate human biological data into targeted medicines; it remains a research and drug-discovery platform rather than an approved treatment provider.